Substituted-8-phenylamino ergolines
US4219556A · kind A · utility
2Cited by
3References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 1, 1978 |
| Grant date | Aug 26, 1980 |
| Priority date | — |
| Expiry date | Sep 1, 1998 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D457/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula I ##STR1## wherein R.sub.1 is hydrogen or lower alkyl, PA1 R.sub.2, R.sub.3 and R.sub.4 are, independently, hydrogen, halogen lower alkyl, lower alkoxy or CONR.sub.5 R.sub.6 wherein R.sub.5 and R.sub.6 are, independently, hydrogen or lower alkyl, and x y is --CH.sub.2 --CH.dbd. or --CH.dbd.C.dbd.. are useful as central dopaminergic agents and prolactin secretion inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.